We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Larch Arabinogalactan
A prebiotic fiber from larch tree bark with a handful of small RCTs suggesting it can boost vaccine antibody responses and modestly reduce common-cold incidence, plus in-vitro evidence of fermentation to short-chain fatty acids. The immune signals are real but the trials are small, industry-sponsored, and use one proprietary extract — emerging evidence.
What the evidence says
Most Larch Arabinogalactan studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality randomised trials published 2010–2023 with a typical study size of 75 participants.
Based on 4 studies · 2 RCTs · 319 total participants
Confidence
LowBy outcome
Larch Arabinogalactan has an evidence score of 3.6/10 — emerging evidence based on 4 indexed studies. A prebiotic fiber from larch tree bark with a handful of small RCTs suggesting it can boost vaccine antibody responses and modestly reduce common-cold incidence, plus in-vitro evidence of fermentation to short-chain fatty acids. The immune signals are real but the trials are small, industry-sponsored, and use one proprietary extract — emerging evidence. Representative study: PMID 24219376.
The commonly studied dose of Larch Arabinogalactan is 1.5-4.5 g/day (doses used in immune RCTs). Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Explore: Best supplements for Vitality & LongevityBest supplements for Body Health
Last reviewed June 2026 · evidence from 4 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Larch arabinogalactan is a soluble prebiotic fiber extracted from the bark of larch trees (Larix species). As a fermentable fiber it is metabolized by gut bacteria — notably Bifidobacterium and Lactobacillus — into short-chain fatty acids, and it is marketed for immune support. The most-cited human evidence comes from small randomized, double-blind, placebo-controlled trials of a single proprietary extract (ResistAid): these showed enhanced IgG antibody responses to tetanus and pneumococcal vaccines and a modest reduction in the number of people affected by common colds over 12 weeks. In-vitro fermentation studies confirm it lowers pH and raises short-chain fatty acids while enriching beneficial bacteria. Honest caveats: the trials are small (45-199 participants), several are industry-funded and use the same branded extract, the cold-prevention result was borderline in the full analysis set, and the influenza-vaccine arm showed no effect. So the prebiotic and immune-priming rationale is plausible and partly supported, but the clinical evidence remains emerging.
Fermented by gut bacteria into short-chain fatty acids, lowering colonic pH and enriching Bifidobacterium and Lactobacillus (shown in-vitro).
Appears to augment the adaptive antibody response to bacterial antigens (tetanus, pneumococcal vaccines) in small human trials; mechanism not fully established.
How Larch Arabinogalactan works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
1.5-4.5 g/day (doses used in immune RCTs)
Can be taken without food
| Form | Type |
|---|---|
| 🧪Soluble fiber powder | Recommended |
| 💊Capsules | Alternative |
Human trials used a single proprietary larch arabinogalactan extract.
Minimum: 4 weeks
Optimal: 12 weeks
Cycling: Not required
Note: Soluble fiber; take with or without food, ideally with adequate water.
Dose-response data unavailable. The current published research for Larch Arabinogalactan does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Increased IgG to tetanus and pneumococcal vaccines in RCTs; no effect on influenza vaccine.
Significantly reduced the number of people affected by a cold over 12 weeks (borderline in full analysis set).
Fermented to SCFAs with enrichment of beneficial bacteria (in-vitro).
May worsen gas/bloating — start low and titrate.
Not specifically studied; dietary fiber is generally considered low-risk, but evidence is limited.
As a soluble fiber it could theoretically slow absorption of some oral drugs; separating doses is prudent though clinically minor.
Tip: Start with a lower dose and increase gradually; ensure adequate water intake
Both are fermentable prebiotic fibers that feed beneficial bacteria via different fermentation profiles.
Broader prebiotic coverage and short-chain fatty acid production across the colon.
Prebiotic fiber provides fermentable substrate that can support probiotic strains (a synbiotic pairing).
Synbiotic support — feeding introduced probiotic bacteria.
Timing is flexible for Larch Arabinogalactan — consistent daily use matters more than the time of day. As a soluble fiber it can be taken with or without food; trials dosed once daily.
Larch Arabinogalactan is generally well-tolerated and considered safe for most healthy adults at recommended doses. The most commonly reported side effects are gas/bloating/flatulence. Use caution if any of these apply to you: Severe fiber intolerance.
A multifunctional iron-binding glycoprotein from milk with broad antimicrobial, anti-inflammatory, and immune-modulating properties.
Tap node to isolate • Pinch to zoom • Tap edge for research